Table 6.

Correlation of factors associated with progression of ci and ct scores

	Δci		Δct
	Mean±SD	p Value	Mean±SD	p Value
Kidney vs SPKT	0.86±0.91 vs 0.67±0.73	0.51	0.85±0.87 vs 0.86±0.65	0.74
DGF (yes vs no)	1.19±0.98 vs 0.62±0.74	0.02	1.15±0.92 vs 0.69±0.72	0.05
Recipient gender (male vs female)	0.83±0.88 vs 0.76±0.83	0.78	0.91±0.83 vs 0.72±0.79	0.35
Donor gender (male vs female)	0.91±0.95 vs 0.69±0.75	0.43	0.88±0.93 vs 0.81±0.67	0.96
Donor source (D vs L)	0.84±0.88 vs 0.75±0.85	0.73	0.87±0.82 vs 0.79±0.83	0.71
Steroid free (no vs yes)	1.09±0.87 vs 0.47±0.74	0.002	1.07±0.83 vs 0.58±0.73	0.01
Acute rejection (yes vs no)	0.8±0.89 vs 0.83±0.82	0.78	0.93±0.84 vs 0.67±0.76	0.23
	R	p Value	R	p Value
Recipient age	−0.11	0.33	−0.11	0.32
Donor age	0.17	0.13	0.04	0.73
HLA MM	−0.09	0.43	−0.002	0.99
Average tacrolimus concentration	−0.009	0.95	0.003	0.98
Average MMF dose	−0.37	<0.001	−0.38	<0.001
ci at implantation	−0.32	0.003
ct at implantation			−0.45	<0.001

DGF, delayed graft function; HLA, human leucocyte antigen; MM, mismatch; SPKT, simultaneous pancreas-kidney transplant.